Frank Czerwiec Email

Chief Medical Officer . Sparrow Pharmaceuticals

Current Roles

Employees:
11
Revenue:
$1.1M
About
Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. Sparrow's pipeline is led by SPI-62 in Phase 2 clinical development.
Sparrow Pharmaceuticals Address
920 SW 6th Avenue
Portland, OR
Sparrow Pharmaceuticals Email

Past Companies

Sparrow Pharmaceuticals, Inc.Chief Medical Officer
Goldfinch BioChief Medical Officer
Otsuka Pharmaceutical Companies (U.S.)Vice President, Global Clinical Development

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.